BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang SC, Yu MY, Xi L, Zhang JX. Tegafur deteriorates established cardiovascular atherosclerosis in colon cancer: A case report and review of the literature. World J Clin Cases 2019; 7(1): 89-94 [PMID: 30637257 DOI: 10.12998/wjcc.v7.i1.89]
URL: https://www.wjgnet.com/2307-8960/full/v7/i1/89.htm
Number Citing Articles
Zhongyi Dong, Bo Ni, Linxi Yang, Yujing Guan, Chunchao Zhu, Enhao Zhao, Gang Zhao, Xiang Xia, Zizhen Zhang. Efficacy and Safety of Camrelizumab in Combination with Docetaxel + S-1 Sequenced by Camrelizumab + S-1 for Stage III (PD-1+/MSI-H/EBV+/dMMR) Gastric Cancer: Study Protocol for a Single-Center, Prospective, Open-Label, Single-Arm TrialFrontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.917352
Adam Buczkowski, Małgorzata Malinowska-Michalak, Artur Stepniak, Pawel Tokarz, Pawel Urbaniak, Bartlomiej Palecz. Calorimetric and spectroscopic studies of interactions of PPI G4 dendrimer with tegafur in aqueous solutionsJournal of Molecular Liquids 2021; 334: 116118 doi: 10.1016/j.molliq.2021.116118
Takuya Oyakawa, Zhensheng Hua, Aya Ebihara, Taro Shiga. A Rare Case of Reversible Cardiac Dysfunction Associated with Tegafur/Gimeracil/Oteracil (S-1) TherapyInternational Heart Journal 2021; 62(3): 700 doi: 10.1536/ihj.20-651
Parul Grover, Kulbhushan Thakur, Monika Bhardwaj, Lovekesh Mehta, Soom Nath Raina, Vijay Rani Rajpal. Phytotherapeutics in Cancer: From Potential Drug Candidates to Clinical TranslationCurrent Topics in Medicinal Chemistry 2024; 24(12): 1050 doi: 10.2174/0115680266282518231231075311